Published in Science on October 30, 1992
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A (1993) 15.04
Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol (1994) 5.12
Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A (1997) 3.42
Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest (1998) 2.68
Genetic prion disease: the EUROCJD experience. Hum Genet (2005) 2.64
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet (2013) 2.44
De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci U S A (2008) 2.10
Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci U S A (1998) 2.02
Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging (2007) 2.00
A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J Virol (1995) 1.87
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A (1994) 1.85
Elimination of prions by branched polyamines and implications for therapeutics. Proc Natl Acad Sci U S A (1999) 1.73
Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc Natl Acad Sci U S A (2001) 1.69
Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A (1993) 1.68
High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am J Hum Genet (2000) 1.61
Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease. PLoS Pathog (2015) 1.54
Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway. Mol Cell Proteomics (2009) 1.52
Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A (2010) 1.51
Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol (1998) 1.48
Cellular biology of prion diseases. Clin Microbiol Rev (1999) 1.48
The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon. Am J Hum Genet (1997) 1.48
Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A (1998) 1.43
The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients. PLoS Pathog (2016) 1.40
The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta (2006) 1.39
Minimotif miner 2nd release: a database and web system for motif search. Nucleic Acids Res (2008) 1.36
Proposed three-dimensional structure for the cellular prion protein. Proc Natl Acad Sci U S A (1994) 1.35
Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). Am J Hum Genet (1993) 1.34
Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele. Am J Hum Genet (1997) 1.34
Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils. Proc Natl Acad Sci U S A (1993) 1.31
Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J (2001) 1.30
The methionine-aromatic motif plays a unique role in stabilizing protein structure. J Biol Chem (2012) 1.28
The yeast prion [URE3] can be greatly induced by a functional mutated URE2 allele. EMBO J (2000) 1.21
Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J Gen Virol (2009) 1.16
Phenotypic variability in familial prion diseases due to the D178N mutation. J Neurol Neurosurg Psychiatry (2005) 1.16
Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet (2000) 1.16
Prion strain-dependent differences in conversion of mutant prion proteins in cell culture. J Virol (2006) 1.14
Identifying modifier genes of monogenic disease: strategies and difficulties. Hum Genet (2008) 1.13
Evidence for the experimental transmission of cerebral beta-amyloidosis to primates. Int J Exp Pathol (1993) 1.10
A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci. Hum Mol Genet (2011) 1.10
Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface. Structure (2013) 1.08
Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding. J Mol Biol (2010) 1.08
Conformational diversity in prion protein variants influences intermolecular beta-sheet formation. EMBO J (2009) 1.07
Prion protein facilitates uptake of zinc into neuronal cells. Nat Commun (2012) 1.07
Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry (1993) 1.06
PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism. BMC Med Genet (2009) 1.06
Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol (2010) 1.06
Molecular evidence of founder effects of fatal familial insomnia through SNP haplotypes around the D178N mutation. Neurogenetics (2008) 1.02
A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP. J Neurosci (2009) 1.00
The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel (2009) 0.98
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. PLoS One (2012) 0.98
Molecular pathology of human prion diseases. Int J Mol Sci (2009) 0.94
Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD. Am J Pathol (2005) 0.93
A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report. BMC Neurol (2010) 0.92
Stability and Cu(II) binding of prion protein variants related to inherited human prion diseases. Biophys J (2003) 0.88
Strain specific resistance to murine scrapie associated with a naturally occurring human prion protein polymorphism at residue 171. PLoS Pathog (2011) 0.88
Prion diseases: what will be next? J Clin Pathol (1998) 0.87
Two different clinical phenotypes of Creutzfeldt-Jakob disease with a M232R substitution. J Neurol (2007) 0.86
Synaptic dysfunction in prion diseases: a trafficking problem? Int J Cell Biol (2013) 0.85
Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene. BMJ Open (2014) 0.85
Nanopore analysis of wild-type and mutant prion protein (PrP(C)): single molecule discrimination and PrP(C) kinetics. PLoS One (2013) 0.85
Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway. J Biol Chem (2012) 0.85
Failure to detect the presence of prions in the uterine and gestational tissues from a Gravida with Creutzfeldt-Jakob disease. Am J Pathol (2009) 0.85
Kuru: genes, cannibals and neuropathology. J Neuropathol Exp Neurol (2012) 0.84
Genotype patterns and characteristics of PRNP in the Korean population. Prion (2012) 0.84
A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes. J Neurol (2012) 0.83
Mouse prion protein polymorphism Phe-108/Val-189 affects the kinetics of fibril formation and the response to seeding: evidence for a two-step nucleation polymerization mechanism. J Biol Chem (2013) 0.83
Prion protein gene analysis in three kindreds with fatal familial insomnia (FFI): codon 178 mutation and codon 129 polymorphism. Am J Hum Genet (1993) 0.82
Mutations at codons 178, 200-129, and 232 contributed to the inherited prion diseases in Korean patients. BMC Infect Dis (2009) 0.81
A polymorphism in the regulatory region of PRNP is associated with increased risk of sporadic Creutzfeldt-Jakob disease. BMC Med Genet (2011) 0.81
A case of dementia with PRNP D178Ncis-129M and no insomnia. Alzheimer Dis Assoc Disord (2009) 0.81
Genetics of narcolepsy and other sleep disorders. Am J Hum Genet (1997) 0.81
Codon 219 polymorphism of PRNP in healthy Caucasians and Creutzfeldt-Jakob disease patients. Am J Hum Genet (1996) 0.81
Pathologic evidence that the T188R mutation in PRNP is associated with prion disease. J Neuropathol Exp Neurol (2010) 0.80
Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype. J Virol (2015) 0.80
Codon 178 mutation of the human prion protein gene in a German family (Backer family): sequencing data from 72-year-old celloidin-embedded brain tissue. Acta Neuropathol (1995) 0.79
Clinical findings and diagnosis in genetic prion diseases in Germany. Eur J Epidemiol (2015) 0.79
Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells. Proc Natl Acad Sci U S A (2016) 0.79
Four is not more than two. Am J Hum Genet (1995) 0.78
Infectious amyloid precursor gene sequences in primates used for experimental transmission of human spongiform encephalopathy. Proc Natl Acad Sci U S A (1994) 0.78
Prions, beta-sheets and transmissible dementias: is there still something missing? Acta Neuropathol (1995) 0.78
Neurodegeneration in humans caused by prions. West J Med (1994) 0.77
Towards authentic transgenic mouse models of heritable PrP prion diseases. Acta Neuropathol (2016) 0.77
A closer look at prion strains: characterization and important implications. Prion (2013) 0.77
Disease-associated mutations in the prion protein impair laminin-induced process outgrowth and survival. J Biol Chem (2012) 0.76
DNA polymorphisms of the prion doppel gene region in four different German cattle breeds and cows tested positive for bovine spongiform encephalopathy. Mamm Genome (2005) 0.76
Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS. Acta Neuropathol (2016) 0.76
Nanopore analysis reveals differences in structural stability of ovine PrP(C) proteins corresponding to scrapie susceptible (VRQ) and resistance (ARR) genotypes. Prion (2014) 0.76
Hereditary Human Prion Diseases: an Update. Mol Neurobiol (2016) 0.76
A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol (2017) 0.75
Clinical, histopathological and genetic studies in a case of fatal familial insomnia with review of the literature. Int J Clin Exp Pathol (2015) 0.75
Perceptions of prion disease. J Clin Pathol (1994) 0.75
The roles of the conserved tyrosine in the β2-α2 loop of the prion protein. Prion (2015) 0.75
Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease. Antioxidants (Basel) (2014) 0.75
Sporadic fatal insomnia in a young woman: a diagnostic challenge: case report. BMC Neurol (2011) 0.75
Inherited prion disease. BMJ (1993) 0.75
Familial fatal insomnia with atypical clinical features in a patient with D178N mutation and homozygosity for Met at codon 129 of the prion protein gene. Prion (2015) 0.75
Polymorphism distribution of prion protein codon 117, 129 and 171 in Taiwan. Eur J Epidemiol (2007) 0.75
Genetic human prion disease modelled in PrP transgenic Drosophila. Biochem J (2017) 0.75
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science (1996) 6.71
'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol (2000) 5.29
Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet (1974) 4.95
Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol (2001) 4.80
Human immunodeficiency virus integration in a cell-free system. J Virol (1990) 4.48
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (1994) 4.24
Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol (1996) 4.10
Genetic control of natural variation in Arabidopsis glucosinolate accumulation. Plant Physiol (2001) 4.07
Ribonucleic acid composition of bacteria as a function of growth rate. J Mol Biol (1966) 3.48
Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet (1995) 3.42
Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med (1992) 3.41
Phylogeny of some Fusarium species, as determined by large-subunit rRNA sequence comparison. Mol Biol Evol (1989) 3.28
Community clinics for leg ulcers and impact on healing. BMJ (1992) 3.28
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev (1999) 2.96
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A (1999) 2.76
Bias inherent in retrospective waiting-time studies: experience from a vascular surgery waiting list. CMAJ (2000) 2.74
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat Med (1996) 2.71
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol (1996) 2.68
Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A (1991) 2.55
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology (2007) 2.51
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Further evidence for small-bodied hominins from the Late Pleistocene of Flores, Indonesia. Nature (2005) 2.47
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
FLP-mediated DNA mobilization to specific target sites in Drosophila chromosomes. Nucleic Acids Res (1997) 2.46
The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology (1987) 2.46
An extremely luminous X-ray outburst at the birth of a supernova. Nature (2008) 2.41
Production and detection of cold antihydrogen atoms. Nature (2002) 2.31
Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man. Exp Brain Res (1993) 2.30
Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology (2000) 2.28
New clinical sign for orthostatic tremor. Lancet (1995) 2.25
Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. FEBS Lett (2000) 2.22
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1998) 2.22
Gastric cancer detection in gastric ulcer disease. Gut (1980) 2.20
Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man. J Pharmacol Exp Ther (1965) 2.16
Bovine spongiform encephalopathy [corrected] Creutzfeldt-Jakob disease. BMJ (1996) 2.15
Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain (2001) 2.14
Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med (1977) 2.10
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol (1986) 2.06
Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med (1986) 2.06
Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc Natl Acad Sci U S A (1988) 2.04
Idiopathic recurring stupor. Neurology (1994) 2.04
Supervised harvesting of expression trees. Genome Biol (2001) 2.02
Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci Lett (2000) 1.98
Estimating cancer risk in relation to tritium exposure from routine operation of a nuclear-generating station in Pickering, Ontario. Chronic Dis Inj Can (2013) 1.97
Presenilin-1 mutations in Alzheimer's disease. Nature (2000) 1.97
Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. Brain (1999) 1.96
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
Chiropractic care of children with nocturnal enuresis: a prospective outcome study. J Manipulative Physiol Ther (1991) 1.85
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85
Assessment of aggression in psychiatric admissions: semistructured interview and case note survey. BMJ (2000) 1.85
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A (1994) 1.85
Collaborative annotation of genes and proteins between UniProtKB/Swiss-Prot and dictyBase. Database (Oxford) (2009) 1.85
Ictal bradycardia in partial epileptic seizures: Autonomic investigation in three cases and literature review. Brain (2001) 1.84
Typing prion isoforms. Nature (1997) 1.82
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci U S A (1999) 1.80
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Clinical signs of early osteoarthritis: reproducibility and relation to x ray changes in 541 women in the general population. Ann Rheum Dis (1991) 1.79
Synthesis in vitro of a seven amino acid peptide encoded in the leader RNA of Rous sarcoma virus. J Mol Biol (1986) 1.78
Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol (1996) 1.77
Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature (2000) 1.77
Kofi Annan describes new health fund for developing countries. BMJ (2001) 1.76
Ionophore toxicity in turkey breeders. Avian Dis (1983) 1.76
Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med (1985) 1.75
Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord (1998) 1.74
Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error. J Clin Pathol (1989) 1.74
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med (1986) 1.73
Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus (2004) 1.73
A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group. Gastroenterology (1994) 1.70
Improvement of stiff-man syndrome with vigabatrin. Neurology (1997) 1.68
Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem (1998) 1.68
Cancer registries fear imminent collapse. BMJ (2000) 1.68
Testing models for genetic determination in migraine. Cephalalgia (1993) 1.67
Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science (1987) 1.67